Jane Street Group LLC Acquires New Position in iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN)

Jane Street Group LLC acquired a new stake in shares of iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 10,150 shares of the company’s stock, valued at approximately $254,000. Jane Street Group LLC owned approximately 0.07% of iShares Neuroscience and Healthcare ETF at the end of the most recent quarter.

iShares Neuroscience and Healthcare ETF Price Performance

IBRN opened at $24.75 on Friday. The stock’s 50 day simple moving average is $26.41 and its 200 day simple moving average is $25.72. iShares Neuroscience and Healthcare ETF has a 1 year low of $22.67 and a 1 year high of $28.74. The firm has a market cap of $3.71 million, a price-to-earnings ratio of 28.31 and a beta of 1.06.

iShares Neuroscience and Healthcare ETF Profile

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap.